{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:14:36Z","timestamp":1771546476240,"version":"3.50.1"},"reference-count":40,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["513781"],"award-info":[{"award-number":["513781"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1042231"],"award-info":[{"award-number":["1042231"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022560","name":"Fremantle Hospital Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>It is uncertain whether subclinical hypothyroidism (SCH) contributes to intrinsic renal dysfunction in people with type 2 diabetes mellitus (T2DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate whether SCH persisting over 4 years is associated with incident impairment of renal function in people with T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Longitudinal observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Urban population of people with type 2 diabetes living in the community and enrolled in a prospective observational study of diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>725 without known thyroid dysfunction at baseline and at follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Changes in estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) in participants stratified by thyroid status at baseline and follow-up into those with euthyroidism or transient or persistent subclinical (SCH)\/overt hypothyroidism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After a mean \u00b1 SD 4.3 \u00b1 0.4 years, 683 participants had stable euthyroidism, 18 transient SCH\/overt hypothyroidism, and 24 persistent SCH\/overt hypothyroidism. No significant changes in eGFR were observed in any group. Those with persistent SCH\/overt hypothyroidism demonstrated a significant increase in ACR, which was not seen in those with euthyroidism and transient SCH\/overt hypothyroidism (\u0394ACR 22.0 \u00b1 81.4 vs 0.4 \u00b1 36.7 and \u22120.3 \u00b1 5.7\u2005mg\/mmol, respectively, P = .027). Similar results were seen when those with baseline ACR &amp;gt; 30\u2005mg\/mmol were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Persistent SCH\/overt hypothyroidism was associated with incident increased albuminuria not observed in euthyroid participants. Assessment of thyroid function in all patients with T2DM may be indicated, as some previous studies provide evidence that thyroxine replacement may ameliorate albuminuria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf485","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:34:14Z","timestamp":1756208054000},"page":"e860-e867","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Subclinical Hypothyroidism on Nephropathy Complicating Type 2 Diabetes: The Fremantle Diabetes Study Phase II"],"prefix":"10.1210","volume":"111","author":[{"given":"S A Paul","family":"Chubb","sequence":"first","affiliation":[{"name":"Medical School, University of Western Australia, Fremantle Hospital , Fremantle, WA 6959 ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A","family":"Davis","sequence":"additional","affiliation":[{"name":"Medical School, University of Western Australia, Fremantle Hospital , Fremantle, WA 6959 ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0749-7411","authenticated-orcid":false,"given":"Timothy M E","family":"Davis","sequence":"additional","affiliation":[{"name":"Medical School, University of Western Australia, Fremantle Hospital , Fremantle, WA 6959 ,","place":["Australia"]},{"name":"Department of Endocrinology and Diabetes, Fiona Stanley and Fremantle Hospitals Group , Murdoch, WA 6150 ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"4","key":"2026021918524320400_dgaf485-B1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ndt\/gfy071","article-title":"Low thyroid function is not associated with an accelerated deterioration in renal function","volume":"34","author":"Meuwese","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2026021918524320400_dgaf485-B2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/s41598-018-19693-4","article-title":"Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study","volume":"8","author":"Chang","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"2026021918524320400_dgaf485-B3","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00592-022-01969-x","article-title":"The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: the Fremantle diabetes study phase II","volume":"59","author":"Chubb","year":"2022","journal-title":"Acta Diabetol"},{"issue":"8","key":"2026021918524320400_dgaf485-B4","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1210\/jc.2013-3778","article-title":"Thyroid status and renal function in older persons in the general population","volume":"99","author":"Meuwese","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026021918524320400_dgaf485-B5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/thy.2010.0411","article-title":"Risk for progression to overt hypothyroidism in an elderly Japanese population with subclinical hypothyroidism","volume":"21","author":"Imaizumi","year":"2011","journal-title":"Thyroid"},{"issue":"6","key":"2026021918524320400_dgaf485-B6","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1210\/jc.2011-3047","article-title":"The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study","volume":"97","author":"Somwaru","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026021918524320400_dgaf485-B7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/EJE-08-0837","article-title":"Thyroid dysfunction and kidney disease","volume":"160","author":"Iglesias","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026021918524320400_dgaf485-B8","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.21608\/ejhm.2021.170514","article-title":"Subclinical and clinical hypothyroidism in proteinuric nephropathies: amelioration of proteinuria and preservation of renal function by thyroid hormone replacement therapy","volume":"83","author":"Hassan","year":"2021","journal-title":"Egypt J Hosp Med"},{"issue":"1","key":"2026021918524320400_dgaf485-B9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7150\/ijms.7186","article-title":"Unresolved subclinical hypothyroidism is independently associated with progression of chronic kidney disease","volume":"11","author":"Kim","year":"2014","journal-title":"Int J Med Sci"},{"issue":"6","key":"2026021918524320400_dgaf485-B10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jpeds.2007.10.050","article-title":"Long-term effects of primary hypothyroidism on renal function in children","volume":"152","author":"Elgadi","year":"2008","journal-title":"J Pediatr"},{"issue":"10","key":"2026021918524320400_dgaf485-B11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCULATIONAHA.124.071079","article-title":"Albuminuria in cardiovascular, kidney, and metabolic disorders: a state-of-the-art review","volume":"151","author":"Claudel","year":"2025","journal-title":"Circulation"},{"issue":"12","key":"2026021918524320400_dgaf485-B12","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1464-5491.2007.02270.x","article-title":"Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients","volume":"24","author":"Chen","year":"2007","journal-title":"Diabet Med"},{"issue":"10","key":"2026021918524320400_dgaf485-B13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1507\/endocrj.EJ14-0206","article-title":"Association between subclinical hypothyroidism and diabetic nephropathy in patients with type 2 diabetes mellitus","volume":"61","author":"Furukawa","year":"2014","journal-title":"Endocr J"},{"issue":"3","key":"2026021918524320400_dgaf485-B14","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.diabres.2011.08.019","article-title":"Subclinical hypothyroidism is independently associated with albuminuria in people with type 2 diabetes","volume":"94","author":"Yasuda","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"2026021918524320400_dgaf485-B15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/cen.14164","article-title":"Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: the Fremantle diabetes study phase II","volume":"92","author":"Peters","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026021918524320400_dgaf485-B16","doi-asserted-by":"crossref","first-page":"e749","DOI":"10.1210\/clinem\/dgaa871","article-title":"Proteinuria in severe hypothyroidism: a prospective study","volume":"106","author":"Gondil","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026021918524320400_dgaf485-B17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12902-024-01779-y","article-title":"The association between thyroid function and insulin resistance as measured by the metabolic score for insulin resistance (METS-IR): insights from NHANES 2007-2012","volume":"24","author":"Safari","year":"2024","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"2026021918524320400_dgaf485-B18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/hr.2011.91","article-title":"Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data","volume":"34","author":"Cai","year":"2011","journal-title":"Hypertens Res"},{"issue":"5","key":"2026021918524320400_dgaf485-B19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.JAA.0000660120.03250.55","article-title":"Subclinical hypothyroidism: to treat or not to treat?","volume":"33","author":"Simon","year":"2020","journal-title":"JAAPA"},{"key":"2026021918524320400_dgaf485-B20","author":"National Institute for Health and Care Excellence","year":"2024"},{"issue":"2","key":"2026021918524320400_dgaf485-B21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ije\/dys065","article-title":"Cohort profile: the Fremantle diabetes study","volume":"42","author":"Davis","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"7","key":"2026021918524320400_dgaf485-B22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/imj.13792","article-title":"The prevalence of diabetes in Australia: insights from the Fremantle diabetes study phase II","volume":"48","author":"Davis","year":"2018","journal-title":"Intern Med J"},{"key":"2026021918524320400_dgaf485-B23","doi-asserted-by":"crossref","first-page":"9241904","DOI":"10.1155\/2018\/9241904","article-title":"Anthropometrics, metabolic syndrome, and mortality hazard","volume":"2018","author":"Krakauer","year":"2018","journal-title":"J Obes"},{"issue":"3","key":"2026021918524320400_dgaf485-B24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2337\/diacare.29.03.06.dc05-1567","article-title":"Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle diabetes study","volume":"29","author":"Norman","year":"2006","journal-title":"Diabetes Care"},{"issue":"5","key":"2026021918524320400_dgaf485-B25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"9","key":"2026021918524320400_dgaf485-B26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"2026021918524320400_dgaf485-B27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","article-title":"Can clinical factors estimate insulin resistance in type 1 diabetes?","volume":"49","author":"Williams","year":"2000","journal-title":"Diabetes"},{"issue":"1","key":"2026021918524320400_dgaf485-B28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12933-021-01394-4","article-title":"Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study","volume":"20","author":"Zabala","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2026021918524320400_dgaf485-B29","author":"University of Oxford. Radcliffe Department of Medicine","year":"2025"},{"issue":"5","key":"2026021918524320400_dgaf485-B30","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/ije\/dyu126","article-title":"Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung health study","volume":"43","author":"Zhang","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2026021918524320400_dgaf485-B31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12902-019-0405-0","article-title":"The longitudinal effect of subclinical hypothyroidism on urine microalbumin-to-urine creatinine ratio in patients with type 2 diabetes mellitus","volume":"19","author":"Xie","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"2026021918524320400_dgaf485-B32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1089\/thy.2017.0517","article-title":"Over- and under-treatment of hypothyroidism is associated with excess mortality: a register-based cohort study","volume":"28","author":"Lillevang-Johansen","year":"2018","journal-title":"Thyroid"},{"key":"2026021918524320400_dgaf485-B33","doi-asserted-by":"crossref","first-page":"l4892","DOI":"10.1136\/bmj.l4892","article-title":"Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study","volume":"366","author":"Thayakaran","year":"2019","journal-title":"BMJ"},{"issue":"10","key":"2026021918524320400_dgaf485-B34","doi-asserted-by":"crossref","first-page":"e110437","DOI":"10.1371\/journal.pone.0110437","article-title":"Duration of thyroid dysfunction correlates with all-cause mortality. The OPENTHYRO register cohort","volume":"9","author":"Laulund","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"2026021918524320400_dgaf485-B35","doi-asserted-by":"crossref","first-page":"e2211863","DOI":"10.1001\/jamanetworkopen.2022.11863","article-title":"Association of thyroid hormone treatment intensity with cardiovascular mortality among US veterans","volume":"5","author":"Evron","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2026021918524320400_dgaf485-B36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-10-0312","article-title":"TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects","volume":"163","author":"Garduno-Garcia","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"11 Pt 1","key":"2026021918524320400_dgaf485-B37","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0895-7061(03)01009-4","article-title":"Association between microalbuminuria and the metabolic syndrome: NHANES III","volume":"16","author":"Palaniappan","year":"2003","journal-title":"Am J Hypertens"},{"issue":"1","key":"2026021918524320400_dgaf485-B38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/etm.2014.2037","article-title":"Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (Review)","volume":"9","author":"Lu","year":"2015","journal-title":"Exp Ther Med"},{"issue":"18","key":"2026021918524320400_dgaf485-B39","doi-asserted-by":"crossref","first-page":"e130249","DOI":"10.1172\/jci.insight.130249","article-title":"Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytes","volume":"4","author":"Benedetti","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"2026021918524320400_dgaf485-B40","doi-asserted-by":"crossref","first-page":"107826","DOI":"10.1016\/j.isci.2023.107826","article-title":"Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs","volume":"26","author":"Lavecchia","year":"2023","journal-title":"iScience"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf485\/64160369\/dgaf485.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/3\/e860\/64160369\/dgaf485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/3\/e860\/64160369\/dgaf485.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:52:54Z","timestamp":1771545174000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/3\/e860\/8243864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,29]]},"published-print":{"date-parts":[[2026,2,20]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf485","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,8,29]]}}}